myogen


Also found in: Medical.

myogen

(ˈmaɪədʒən; ˈmaɪəʊˌdʒɛn)
n
(Biochemistry) any of several proteins found in muscle
References in periodicals archive ?
Previously, Calhoun was a member of the boards and audit committees of Abraxis Bioscience, Myogen, Aspreva Pharmaceuticals Company, Replidyne and Adams Respiratory Therapeutics.
Prior to his work on the Anschutz campus, Poticha served as a corporate attorney for Colorado-based pharmaceutical company, Myogen, Inc., which was subsequently acquired by Gilead Sciences.
Acute injections of rhEPO (15,000 IU) did not change mRNA levels of VEGF, hypoxia-inducible factor 1[alpha] (HIF-1[alpha]), insulin-like growth factor, ferroportin, myogenic differentiation 1 (MyoD), and myogen in biopsies obtained 2, 4, 6, and 10 h after injection of rhEPO, while small inductions of myoglobin, EPO-R, transferrin receptor, and myogenic regulatory factor (MRF4) were observed (39).
Clemmensen, Abbot, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, EliLilly, Evolva, Fibrex, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Sanofi, Searle, and Servier; J.
Lifetime Achievement Award - William Freytag, Ph.D., Former Chairman and CEO, Myogen (Boulder)
He was the principal founder of Myogen, a biopharmaceutical company focused on the discovery, development and commercialisation of therapeutics for the treatment of cardiovascular and pulmonary disease.
He has been a consultant to Merck, GlaxoSmithKline, Bristol Myers Squibb, Novartis, CVRx, and Myogen.
Most recently, Mr Turner served as CFO at Myogen, a biopharmaceutical company, which he joined in 1999 and served until it was acquired by Gilead Sciences in 2006.
He has been a consultant to Merck, GlaxoSmithKline, Bristol-Myers Squibb, No-vartis, CVRx Inc, and Myogen Inc.
Select Pharma-Biotech And Biotech-Biotech Acquisitions Acquirer Acquired Premium Main Reason AstraZeneca Cambridge Antibody ~72% Technology Technology And Products Lilly Icos ~24% Product Gilead Myogen ~49% Product Sciences Merck Sirna ~95% Technology GenZyme AnorMed ~170% Product Stiefel Connectics -45% Product Genentech Tanox -47% Product Source: Reuters; Prudential Equity Group, LLC.
(39.) Myogen reports results for the integrated analysis of ARIES-1 and ARIES-2 pivotal trials of ambrisentan in pulmonary arterial hypertension; significant improvements observed for all primary and secondary endpoints.
Flolan is a specialty medication marketed by Myogen, Inc.